Measuring human heart muscle viability using myocardial electrical impedance
US7657309B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | May 28, 2004 |
| Grant date | Feb 2, 2010 |
| Priority date | — |
| Expiry date | Jun 7, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B5/413
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A method for detecting a quantitative measure of a physiologic state of a human myocardium or coronary artery. Implementations of the method detect the extent of change of myocardial electrical impedance from a mean baseline value to provide diagnosis of the extent of ischemia, stenosis, tissue rejection, and reperfusion and the effectiveness of cardioplegia and ischemia pre-conditioning as well as the general effectiveness of coronary bypass surgery as measured by post-operative reperfusion. Electrodes are attached to the myocardium, baseline measurements of the mean myocardial electrical impedance are stored and the variance of the myocardial electrical impedance and a baseline value of mean myocardial electrical impedance are computed from the baseline measurements and stored. Mean myocardial electrical impedance values are periodically measured between each electrode pair over an interval of time and stored. After the mean myocardial electrical impedance changes from the computed baseline value by at least the measured variance, the extent of change in the myocardial physiologic state is diagnosed as a continuous, smooth, function of the extent of change, or rate of change, of …
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.